My watch list
my.bionity.com  
Login  

Phase I Studies

News Phase I Studies

  • CureVac enters clinical phase with mRNA vaccine

    CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced the initiation of its Phase I dose-escalation clinical trial with the novel mRNA-based rabies vaccine, CV7202. This is the first-in-human clinical trial of CureVac’s naturally optimized more

  • Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106

    Galapagos NV and MorphoSys AG announced the initiation of a Phase 1 bridging study testing a subcutaneous formulation of MOR106, an investigational antibody directed against IL-17C. This bridging study is a parallel-design Phase 1 clinical trial conducted in two parts. Part 1 is a single center, ran more

  • Ablynx to receive milestone for bi-specific nanobody in oncology

    Ablynx announced that Boehringer Ingelheim has administered the first dose in a Phase I dose escalation study with the half-life extended bi-specific anti-VEGF/Ang2 Nanobody® in adult patients with advanced solid tumors, triggering an €8 million milestone payment to Ablynx. The aim of the study is t more

All news on phase i studies

Publications Phase I Studies

All publications on phase i studies

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE